These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Human Genetics and the Causal Role of Lipoprotein(a) for Various Diseases. Kronenberg F Cardiovasc Drugs Ther; 2016 Feb; 30(1):87-100. PubMed ID: 26896185 [TBL] [Abstract][Full Text] [Related]
4. Prediction of cardiovascular risk by Lp(a) concentrations or genetic variants within the LPA gene region. Kronenberg F Clin Res Cardiol Suppl; 2019 Apr; 14(Suppl 1):5-12. PubMed ID: 30859385 [TBL] [Abstract][Full Text] [Related]
5. Lipoprotein(a): more interesting than ever after 50 years. Dubé JB; Boffa MB; Hegele RA; Koschinsky ML Curr Opin Lipidol; 2012 Apr; 23(2):133-40. PubMed ID: 22327610 [TBL] [Abstract][Full Text] [Related]
6. Lipoprotein(a): An independent, genetic, and causal factor for cardiovascular disease and acute myocardial infarction. Enas EA; Varkey B; Dharmarajan TS; Pare G; Bahl VK Indian Heart J; 2019; 71(2):99-112. PubMed ID: 31280836 [TBL] [Abstract][Full Text] [Related]
7. Lipoprotein(a): an important cardiovascular risk factor and a clinical conundrum. Koschinsky ML; Boffa MB Endocrinol Metab Clin North Am; 2014 Dec; 43(4):949-62. PubMed ID: 25432390 [TBL] [Abstract][Full Text] [Related]
8. Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology. Nordestgaard BG; Langsted A J Lipid Res; 2016 Nov; 57(11):1953-1975. PubMed ID: 27677946 [TBL] [Abstract][Full Text] [Related]
10. Estimation of the Required Lipoprotein(a)-Lowering Therapeutic Effect Size for Reduction in Coronary Heart Disease Outcomes: A Mendelian Randomization Analysis. Lamina C; Kronenberg F; JAMA Cardiol; 2019 Jun; 4(6):575-579. PubMed ID: 31017618 [TBL] [Abstract][Full Text] [Related]
11. Association between lipoprotein(a) (Lp(a)) levels and Lp(a) genetic variants with coronary artery calcification. Pechlivanis S; Mahabadi AA; Hoffmann P; Nöthen MM; Broecker-Preuss M; Erbel R; Moebus S; Stang A; Jöckel KH BMC Med Genet; 2020 Mar; 21(1):62. PubMed ID: 32220223 [TBL] [Abstract][Full Text] [Related]
12. Ionizing radiation and genetic risks. VI. Chronic multifactorial diseases: a review of epidemiological and genetical aspects of coronary heart disease, essential hypertension and diabetes mellitus. Sankaranarayanan K; Chakraborty R; Boerwinkle EA Mutat Res; 1999 Jan; 436(1):21-57. PubMed ID: 9878681 [TBL] [Abstract][Full Text] [Related]
13. Evidence for several independent genetic variants affecting lipoprotein (a) cholesterol levels. Lu W; Cheng YC; Chen K; Wang H; Gerhard GS; Still CD; Chu X; Yang R; Parihar A; O'Connell JR; Pollin TI; Angles-Cano E; Quon MJ; Mitchell BD; Shuldiner AR; Fu M Hum Mol Genet; 2015 Apr; 24(8):2390-400. PubMed ID: 25575512 [TBL] [Abstract][Full Text] [Related]
14. A critical evaluation of the role of Lp(a) in cardiovascular disease: can Lp(a) be useful in risk assessment? Marcovina SM; Koschinsky ML Semin Vasc Med; 2002 Aug; 2(3):335-44. PubMed ID: 16222623 [TBL] [Abstract][Full Text] [Related]
15. Lipoprotein (a): truly a direct prothrombotic factor in cardiovascular disease? Boffa MB; Koschinsky ML J Lipid Res; 2016 May; 57(5):745-57. PubMed ID: 26647358 [TBL] [Abstract][Full Text] [Related]
16. A Test in Context: Lipoprotein(a): Diagnosis, Prognosis, Controversies, and Emerging Therapies. Tsimikas S J Am Coll Cardiol; 2017 Feb; 69(6):692-711. PubMed ID: 28183512 [TBL] [Abstract][Full Text] [Related]
17. Lipoprotein(a): a causal independent risk factor for coronary heart disease? Gudnason V Curr Opin Cardiol; 2009 Sep; 24(5):490-5. PubMed ID: 19623058 [TBL] [Abstract][Full Text] [Related]
18. [Research progress in lipoprotein (a): aspects of biochemistry and molecular biology]. Huang YT Sheng Li Ke Xue Jin Zhan; 1996 Jan; 27(1):25-30. PubMed ID: 8731979 [TBL] [Abstract][Full Text] [Related]